Kidney Failure, Chronic: all 2,121 studies
Page 19 of 22. Open to participants first (264), then studies with results posted, then the rest; newest registration first within each.
- HeRO Vascular Access Device Post Market Procedural Survey ProtocolCompletedNCT00889291
- Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease SubjectsCompletedNCT00888069Phase 1
- The Effectiveness and the Safety of Acupuncture for Symptomatic Care of Hemodialysis Patients: A Case-seriesCompletedNCT00883831Not applicable
- Autonomic Dysfunction and Inflammation in Chronic Hemodialysis PatientsCompletedNCT00878033
- Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal DialysisCompletedNCT00865449Phase 3
- The Effect of Oxygen on Healing an Artery From the "Injury" of SurgeryTerminatedNCT00863603Not applicable
- Study of Safety and Efficacy on New Peritoneal Dialysis SolutionsWithdrawnNCT00858182Phase 2
- Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)CompletedNCT00854139Phase 1
- Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal DiseaseStatus unknownNCT00852787Phase 4
- New Non-invasive Methods for Real-time Monitoring of Organ Function.CompletedNCT00851851
- L-Carnitine as an Osmo-metabolic Agent for Peritoneal DialysisCompletedNCT00851838Phase 2
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer HydrochlorideTerminatedNCT00844662Phase 3
- Fluid Intake in Kidney FailureCompletedNCT00842322Not applicable
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum CarbonateTerminatedNCT00841126Phase 3
- Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)WithdrawnNCT00837655Not applicable
- Arteriovenous Fistula Tissue Bank for Pre- and Post-Fistula Placement SpecimensCompletedNCT00836862
- Relevance of Flavanols for Cardiovascular Function in End-Stage Renal DiseaseWithdrawnNCT00835887Phase 2
- An Evaluation of the Causes of Anemia in Patients With Heart FailureCompletedNCT00834691
- An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease PatientsStatus unknownNCT00834301Phase 2
- Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal FailureCompletedNCT00828776Phase 2/3
- The Clinical Evaluation of the Dose of Erythropoietins TrialCompletedNCT00827021Phase 3
- Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney DiseaseCompletedNCT00806481Phase 2
- Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis PatientsCompletedNCT00806130
- Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood LineCompletedNCT00804453Not applicable
- Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis PatientsCompletedNCT00798993Phase 4
- Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PDCompletedNCT00794326Phase 3
- Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)CompletedNCT00792857Phase 1
- Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation ProgramCompletedNCT00792454Not applicable
- Saving Residual Renal Function Among Haemodialysis Patients Receiving IrbesartanCompletedNCT00791830Phase 3
- Comparison of Conventional Dialysis and the Allient SystemStatus unknownNCT00788905Not applicable
- A Randomized Trial to Reduce the Disparity in Live Donor Kidney TransplantationCompletedNCT00785265Not applicable
- Reduction of Heparin Dose in Dialysis With Evodial SystemCompletedNCT00781690Not applicable
- Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein MetabolismTerminatedNCT00776191Phase 4
- Safety of Immunosuppression Minimization in Children and Adolescents After Kidney TransplantationCompletedNCT00768729Phase 1
- Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard DialysisCompletedNCT00766792Not applicable
- Pilot-Scale Clinical Trials of Kibow Biotics® in Chronic Kidney FailureCompletedNCT00760162
- Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)CompletedNCT00755456Phase 2
- Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)WithdrawnNCT00755404Phase 2
- Renal Denervation in End Stage Renal Disease Patients With Refractory HypertensionCompletedNCT00753116Phase 1
- Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?CompletedNCT00749619Phase 3
- Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsCompletedNCT00745914Not applicable
- Parathyroidectomy in Endstage Renal DiseaseCompletedNCT00745719Not applicable
- Sevelamer Hydrochloride in Peritoneal Dialysis PatientsCompletedNCT00745589Not applicable
- Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis PatientsCompletedNCT00745225Phase 4
- Evaluating the Effect of Cromolyn Sodium in Uremic PruritusCompletedNCT00745199Phase 2
- Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent ActivityCompletedNCT00744445Phase 2
- Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney DiseaseCompletedNCT00742716Phase 2
- Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis PatientsTerminatedNCT00739843
- Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injectorCompletedNCT00738205
- Clinical Diagnosis of Teenagers Admitted to Pediatric DepartmentsCompletedNCT00735540
- A Study of Drug-Induced Kidney DiseaseStatus unknownNCT00729014
- The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis PatientsCompletedNCT00727519Phase 3
- Impact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal DiseaseCompletedNCT00718848
- Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4
- Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal FailureCompletedNCT00716573Phase 4
- Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary ProcedureStatus unknownNCT00716001Phase 4
- An Observational Study of Pruritus Amongst Hemodialysis PatientsStatus unknownNCT00715260
- High Flux Hemodialysis Thrice Versus OnceStatus unknownNCT00714662Phase 3
- Immediate Maintained Cannulation of a Newly Implanted Prosthetic Arteriovenous Access for Acute HemodialysisStatus unknownNCT00711750
- Detection of Latent Tuberculosis in Hemodialysis PatientsCompletedNCT00695734
- Vascular Calcification's Risk Factors in Haemodialysis PatientsCompletedNCT00694824
- Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal DiseaseCompletedNCT00692562Phase 1/2
- Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis PatientsCompletedNCT00692068
- Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease PatientsCompletedNCT00687258Phase 2
- Peroral Supplemental Nutrition in End-stage Renal Disease With and Without HIV ComorbidityCompletedNCT00687050Not applicable
- Immune Effects of Vitamin D in Hemodialysis PatientsCompletedNCT00686751Phase 2
- Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal TransplantationCompletedNCT00656695Phase 4
- Vitamin D, Insulin Resistance and Inflammation in ESRDCompletedNCT00656032Phase 2
- Omega-3 Fatty Acid Administration in Dialysis PatientsCompletedNCT00655525Phase 2
- A Clinical Trial of IntensiVE DialysisCompletedNCT00649298Phase 4
- A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal DialysisCompletedNCT00646035Phase 3
- Chronic Kidney Disease Prevention of An-Lo District, KeelungCompletedNCT00644046Phase 4
- The Effect of Nocturnal Haemodialysis on Arterial StiffnessCompletedNCT00641875
- A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for DialysisStatus unknownNCT00628680Phase 3
- T-Wave Alternans in Dialysis PatientsCompletedNCT00621426
- Cognitive Behavioral Treatment of Depression in ESRD Patients on DialysisCompletedNCT00618475Not applicable
- Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis PatientsCompletedNCT00618033Not applicable
- A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated BacteremiaCompletedNCT00614679Phase 1
- Identification of Cardiovascular Risk Factors Linked to Renal Failure ProgressionCompletedNCT00608998
- Live Kidney Donor StudyCompletedNCT00608283
- Comparison of Dialysis Therapies on Cognitive FunctionCompletedNCT00597103
- Impact of Providing High Protein Bar to Dialysis Patients With Low Serum AlbuminCompletedNCT00597025Not applicable
- Arterial pH and Total Body Nitrogen Balances in APDCompletedNCT00586131Phase 4
- More Frequent Dialysis (>3 Treatments Per Week)CompletedNCT00575497Not applicable
- Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal DiseaseWithdrawnNCT00573547Phase 4
- Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)CompletedNCT00567723
- Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney DiseaseCompletedNCT00566670
- A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal FailureCompletedNCT00565994
- Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal AnemiaCompletedNCT00563446Not applicable
- Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis PatientsTerminatedNCT00563342Phase 2
- Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron AdministrationStatus unknownNCT00560976Not applicable
- Nutrient Levels Alter Transplant OutcomeCompletedNCT00560014Not applicable
- Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage DisequilibriumCompletedNCT00559767
- Native Kidney Denervation in Patients With End Stage Renal DiseaseCompletedNCT00551304Phase 1
- Left Ventricular Hypertrophy and Spironolactone in End Stage Renal DiseaseWithdrawnNCT00548912Phase 4
- Comparison Between Effects of Two Iron Preparations on Protein in the UrineCompletedNCT00534144Phase 1
- Myfortic vs. Cellcept in Kidney Transplant RecipientsCompletedNCT00533624Phase 2/3
- N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal FailureStatus unknownNCT00532688Phase 2/3
- Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis PatientsStatus unknownNCT00532597Phase 4
- CBT to Treat Depression in Renal PatientsStatus unknownNCT00530296Not applicable